The goal of this clinical trial is to evaluate the effectiveness of a non-ablative 1470 nm laser in treating scarring alopecia in adults. The study will also investigate the biochemical molecular pathways involved in laser therapy by analyzing hair follicle gene expression before and after laser treatment. The main questions it aims to answer are: 1. Does a non-ablative laser work to effectively treat scarring alopecia? 2. What molecular pathways are associated with the laser's effects on hair follicles in scarring alopecia? Participants with scarring alopecia will: * Receive 3 laser treatments, spaced 1 month apart (Month 1, Month 2, Month 3), and attend 5 follow-up visits (Month 4, Month 6, Month 9, Month 12 and Month 15) * Have hair follicle samples collected via hair plucking of 10 hairs prior to the start and 1-month post-completion of laser treatments for gene expression analysis of inflammatory and fibrosis pathways implicated in scarring alopecia. Hair samples will be de-identified and kept anonymous. * Fill out questionnaires at each visit * Keep a diary of any side effects from laser treatments
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Clinician Global Aesthetic Improvement Scale
Timeframe: Month 2, Month 3, Month 4, Month 6, Month 9, Month 12, Month 15
Subject Global Aesthetic Improvement Scale
Timeframe: Month 2, Month 3, Month 4, Month 6, Month 9, Month 12, Month 15
Hair density
Timeframe: Baseline/Month 1, 2, 3, 4, 6, 9, 12, 15
Hair counts
Timeframe: Baseline/Month 1, 2, 3, 4, 6, 9, 12, 15